On one hand, this study demonstrated the important activity of SINEs, regardless NPM1 mutational status; on the other, it revealed that in AML, in the presence of a p53 mutation, SINEs’ activity was sensibly decreased. Here, TP53 is linked to acute myeloid leukemia.